LFCR vs TPR · $207.1M cap vs P/E 46, rev $8.00B
Lifecore Biomedical Inc. (LFCR) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
LFCR does not have a complete income-statement cache yet.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
LFCR currently screens at market cap $207.1M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the LFCR and TPR stock pages for the full models.
Not investment advice.